Concepedia

Randall Lanier

RL

Statistics

Publications

21

Citations

1.3K

H-Index

17

Active since

1998

Affiliations

Research Triangle Park Foundation(Current)

Chimerix (United States)

Saint Louis University

GlaxoSmithKline (United States)

University College London

Randall Lanier is an author at Research Triangle Park Foundation specializing in infectious diseases, antiviral therapy, and molecular virology.

Publications per year

1998–2020

21

Publications

21

The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan

Victor DeGruttola, Lynn P. Dix, Richard T. D’Aquila et al. · Antiviral Therapy · 2000 · 330 citations · Full text

, , +13

Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

Diana F. Florescu, Steven A. Pergam, Michael Neely et al. · Biology of Blood and Marrow Transplantation · 2011 · 174 citations · Full text

, , +16

Development of CMX001 for the Treatment of Poxvirus Infections

Randall Lanier, Lawrence C. Trost, Tim Tippin et al. · Viruses · 2010 · 163 citations · Full text

, , +14

A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects

Schlomo Staszewski, Christine Katlama, Thomas Harrer et al. · AIDS · 1998 · 87 citations

, , +17

Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns

Françoise Brun‐Vézinet, Dominique Costagliola, Mounir Ait Khaled et al. · Antiviral Therapy · 2004 · 65 citations · Full text

, , +17

1–5 of 21